Cargando…
miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction
BACKGROUND & AIMS: Metabolism supports cell proliferation and growth. Surprisingly, the tumor suppressor miR-22 is induced by metabolic stimulators like bile acids. Thus, this study examines whether miR-22 could be a metabolic silencer. METHODS: The relationship between miR-22 and the expression...
Autores principales: | Hu, Ying, Liu, Hui-Xin, Jena, Prasant Kuma, Sheng, Lili, Ali, Mohamed R., Wan, Yu-Jui Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078383/ https://www.ncbi.nlm.nih.gov/pubmed/32195457 http://dx.doi.org/10.1016/j.jhepr.2020.100093 |
Ejemplares similares
-
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012) -
FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation
por: Keinicke, Helle, et al.
Publicado: (2020) -
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018) -
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
por: Park, Jong-Gil, et al.
Publicado: (2016) -
MiR‐22 modulates the expression of lipogenesis‐related genes and promotes hepatic steatosis in vitro
por: Yang, Zhuo, et al.
Publicado: (2020)